Complete sequence and genomic analysis of rhesus cytomegalovirus

Journal of Virology

Volumn 77, Issue 12, 2003, Pages 6620-6636

  Hansen, Scott G ^a   Strelow, Lisa I ^a,b   Franchi, David C ^c   Anders, David G ^c   Wong, Scott W ^a,b,d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c WADSWORTH CENTER   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYTOSINE; G PROTEIN COUPLED RECEPTOR; GUANINE; VIRUS DNA; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; BETAHERPESVIRINAE; CODON; CYTOMEGALOVIRUS; DNA BASE COMPOSITION; DNA SEQUENCE; EXON; INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; RHESUS MONKEY; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION; VIRION; VIROGENESIS; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; CELLS, CULTURED; CYTOMEGALOVIRUS; DNA, VIRAL; GENOME, VIRAL; HUMANS; MACACA MULATTA; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PHYLOGENY; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS;

EID: 0037604819     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.12.6620-6636.2003     Document Type: Article

References (79)

1. Al-Barazi, H. O., and A. M. Colberg-Poley. 1996. The human cytomegalovirus UL37 immediate-early regulatory protein is an integral membrane N-glycoprotein which traffics through the endoplasmic reticulum and Golgi apparatus. J. Virol. 70:7198-7208.
2. Alcendor, D. J., P. A. Barry, E. Pratt-Lowe, and P. A. Luciw. 1993. Analysis of the rhesus cytomegalovirus immediate-early gene promoter. Virology 194:815-821.
3. Asher, D. M., C. J. Gibbs, Jr., D. J. Lang, D. C. Gajdusek, and R. M. Chanock. 1974. Persistent shedding of cytomegalovirus in the urine of healthy Rhesus monkeys. Proc. Soc. Exp. Biol. Med. 145:794-801.
4. Atalay, R., A. Zimmermann, M. Wagner, E. Borst, C. Benz, M. Messerle, and H. Hengel. 2002. Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcγ receptor homologs. J. Virol. 76:8596-8608.
5. Bahr, U., and G. Darai. 2001. Analysis and characterization of the complete genome of tupaia (tree shrew) herpesvirus. J. Virol. 75:4854-4870.
6. Baldick, C. J., Jr., and T. Shenk. 1996. Proteins associated with purified human cytomegalovirus particles. J. Virol. 70:6097-6105.
7. Barry, P. A., D. J. Alcendor, M. D. Power, H. Kerr, and P. A. Luciw. 1996. Nucleotide sequence and molecular analysis of the rhesus cytomegalovirus immediate-early gene and the UL121-117 open reading frames. Virology 215:61-72.
8. Baskin, G. B. 1987. Disseminated cytomegalovirus infection in immunodeficient rhesus monkeys. Am. J. Pathol. 129:345-352.
9. Boccuni, M. C., F. Campanini, M. C. Battista, G. Bergamini, P. Dal Monte, A. Ripalti, and M. P. Landini. 1998. Human cytomegalovirus product UL44 downregulates the transactivation of HIV-1 long terminal repeat. AIDS 12:365-372.
10. Bogner, E., M. Reschke, B. Reis, T. Mockenhaupt, and K. Radsak. 1993. Identification of the gene product encoded by ORF UL56 of the human cytomegalovirus genome. Virology 196:290-293.
11. Bourn, H. R., D. A. Sanders, and F. McCormick. 1990. The GTPase super-family: a conserved switch for diverse cell functions. Nature 348:125-132.
12. Britt, W. S., and C. A. Alford. 1996. Cytomegalovirus, p. 2493-2523. In B. Fields et al. (ed.), Field's virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
13. Chang, W. L., and P. A. Barry. 2003. Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis. J. Virol. 77:5073-5083.
14. Colberg-Poley, A. M. 1996. Functional roles of immediate early proteins encoded by the human cytomegalovirus UL36-38, UL115-119, TRS1/IRS1 and US3 loci. Intervirology 39:350-360.
15. Covell, W. 1932. Occurrence of intranuclear inclusions of monkeys unaccompanied by specific signs of disease. Am. J. Pathol. 8:151-158.
16. Cowdy, W., and G. Scott. 1935. Nuclear inclusions in kidneys of macaque rhesus monkeys. Am. J. Pathol. 11:649-658.
17. Drew, W. L., R. C. Miner, D. F. Busch, S. E. Follansbee, J. Gullett, S. G. Mehalko, S. M. Gordon, W. F. Owen, Jr., T. R. Matthews, W. C. Buhles, et al. 1991. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J. Infect. Dis. 163:716-719.
18. Eizuru, Y., K. Tsuchiya, R. Mori, and Y. Minamishima. 1989. Immunological and molecular comparison of simian cytomegaloviruses isolated from African green monkey (Cercopithecus aethiops) and Japanese macaque (Macaca fuscata). Arch. Virol. 107:65-75.
19. Erice, A., S. Chou, K. K. Biron, S. C. Stanat, H. H. Balfour, Jr., and M. C. Jordan. 1989. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N. Engl. J. Med. 320:289-293.
20. Everett, R. D. 1984. Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J. 3:3135-3141.
21. Ewing, B., and P. Green. 1998. Base-calling of automated sequencer traces with phred. II. Error probabilities. Genome Res. 8:186-194.
22. Ewing, B., L. Hillier, M. C. Wendl, and P. Green. 1998. Base-calling of automated sequencer traces with Phred. I. Accuracy assessment. Genome Res. 8:175-185.
23. Fish, K. N., C. Soderberg-Naucler, L. K. Mills, S. Stenglein, and J. A. Nelson. 1998. Human cytomegalovirus persistently infects aortic endothelial cells. J. Virol. 72:5661-5668.
24. Fruh, K., and Y. Yang. 1999. Antigen presentation by MHC class I and its regulation by interferon gamma. Curr. Opin. Immunol. 11:76-81.
25. Geginat, G., W. Hampl, and T. Mertens. 1992. Human cytomegalovirus - biology and infection. Med. Klin. 87:3-10.
26. Gibson, W., R. van Breemen, A. Fields, R. LaFemina, and A. Irmiere. 1984. D,L-α-Difluoromethylornithine inhibits human cytomegalovirus replication. J. Virol. 50:145-154.
27. Goldmacher, V. S., L. M. Bartle, A. Skaletskaya, C. A. Dionne, N. L. Kedersha, C. A. Vater, J. W. Han, R. J. Lutz, S. Watanabe, E. D. Cahir McFarland, E. D. Kieff, E. S. Mocarski, and T. Chittenden. 1999. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl. Acad. Sci. USA 96:12536-12541.
28. Gompels, U. A., J. Nicholas, G. Lawrence, M. Jones, B. J. Thomson, M. E. Martin, S. Efstathiou, M. Craxton, and H. A. Macaulay. 1995. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 209:29-51.
29. Green, P. 1996. DOE Human Genome Program Contractor, p. 157. Grantee Workshop V. Department of Energy, Washington, D.C.
30. Grefte, A., M. C. Harmsen, M. van der Giessen, S. Knollema, W. J. van Son, and T. H. The. 1994. Presence of human cytomegalovirus (HCMV) immediate early mRNA but not ppUL83 (lower matrix protein pp65) mRNA in polymorphonuclear and mononuclear leukocytes during active HCMV infection. J. Gen. Virol. 75:1989-1998.
31. Griffith, B. P., and M. J. Aquino-de Jesus. 1991. Guinea pig model of congenital cytomegalovirus infection. Transplant Proc. 23:29-31, discussion 31.
32. Hahn, G., R. Jores, and E. S. Mocarski. 1998. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA 95:3937-3942.
33. Hobom, U., W. Brune, M. Messerle, G. Hahn, and U. H. Koszinowski. 2000. Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J. Virol. 74:7720-7729.
34. Honess, R. W. 1984. Herpes simplex and 'the herpes complex': diverse observations and a unifying hypothesis. The eighth Fleming lecture. J. Gen. Virol. 65:2077-2107.
35. Honess, R. W., U. A. Gompels, B. G. Barrell, M. Craxton, K. R. Cameron, R. Staden, Y. N. Chang, and G. S. Hayward. 1989. Deviations from expected frequencies of CpG dinucleotides in herpesvirus DNAs may be diagnostic of differences in the states of their latent genomes. J. Gen. Virol. 70:837-855.
36. Huber, M. T., and T. Compton. 1998. The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex. J. Virol. 72:8191-8197.
37. Iskenderian, A. C., L. Huang, A. Reilly, R. M. Stenberg, and D. G. Anders. 1996. Four of eleven loci required for transient complementation of human cytomegalovirus DNA replication cooperate to activate expression of replication genes. J. Virol. 70:383-392.
38. Jabs, D. A., and P. D. Griffiths. 2002. Fomivirsen for the treatment of cytomegalovirus retinitis. Am. J. Ophthalmol. 133:552-556.
39. Kalter, S. S., and R. L. Heberling. 1990. Primate viral diseases in perspective. J. Med. Primatol. 19:519-535.
40. Kerry, J. A., M. A. Priddy, T. Y. Jervey, C. P. Kohler, T. L. Staley, C. D. Vanson, T. R. Jones, A. C. Iskenderian, D. G. Anders, and R. M. Stenberg. 1996. Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infection. J. Virol. 70:373-382.
41. Kessler, M. J., W. T. London, D. L. Madden, J. M. Dambrosia, J. K. Hilliard, K. F. Soike, and R. G. Rawlins. 1989. Serological survey for viral diseases in the Cayo Santiago rhesus macaque population. P. R. Health Sci. J. 8:95-97.
42. Kollert-Jons, A., E. Bogner, and K. Radsak. 1991. A 15-kilobase-pair region of the human cytomegalovirus genome which includes US1 through US13 is dispensable for growth in cell culture. J. Virol. 65:5184-5189.
43. Kondo, K., H. Kaneshima, and E. S. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 91:11879-11883.
44. Kondo, K., J. Xu, and E. S. Mocarski. 1996. Human cytomegalo-virus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc. Natl. Acad. Sci. USA 93:11137-11142.
45. LaFemina, R. L., and G. S. Hayward. 1980. Structural organization of the DNA molecules from human cytomegalovirus. ICN-UCLA Symp. Mol. Biol. 18:39-55.
46. Leatham, M. P., P. R. Witte, and M. F. Stinski. 1991. Alternate promoter selection within a human cytomegalovirus immediate-early and early transcription unit (UL119-115) defines true late transcripts containing open reading frames for putative viral glycoproteins. J. Virol. 65:6144-6153.
47. Littler, E., A. D. Stuart, and M. S. Chee. 1992. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 358:160-162.
48. Lockridge, K. M., S. S. Zhou, R. H. Kravitz, J. L. Johnson, E. T. Sawai, E. L. Blewett, and P. A. Barry. 2000. Primate cytomegaloviruses encode and express an IL-10-like protein. Virology 268:272-280.
49. London, W. T., A. J. Martinez, S. A. Houff, W. C. Wallen, B. L. Curfman, R. G. Traub, and J. L. Sever. 1986. Experimental congenital disease with simian cytomegalovirus in rhesus monkeys. Teratology 33:323-331.
50. Matthews, T., and R. Boehme. 1988. Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Dis. 10:S490-S494.
51. McGeoch, D. J., S. Cook, A. Dolan, F. E. Jamieson, and E. A. Telford. 1995. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J. Mol. Biol. 247:443-458.
52. Nicholas, J. 1996. Determination and analysis of the complete nucleotide sequence of human herpesvirus. J. Virol. 70:5975-5989.
53. Ohtaki, S., H. Kodama, R. Hondo, and T. Kurata. 1986. Activation of cytomegalovirus infection in immunosuppressed cynomolgus monkeys inoculated with varicella-zoster virus. Acta Pathol. Jpn. 36:1537-1552.
54. Pari, G. S., and D. G. Anders. 1993. Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus ori-Lyt-dependent DNA replication. J. Virol. 67:6979-6988.
55. Paterson, D. A., A. P. Dyer, R. S. Milne, E. Sevilla-Reyes, and U. A. Gompels. 2002. A role for human cytomegalovirus glycoprotein O (gO) in cell fusion and a new hypervariable locus. Virology 293:281-294.
56. Pignatelli, S., P. Dal Monte, G. Rossini, S. Chou, T. Gojobori, K. Hanada, J. J. Guo, W. Rawlinson, W. Britt, M. Mach, and M. P. Landini. 2003. Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J. Gen. Virol. 84:647-655.
57. Plachter, B., C. Sinzger, and G. Jahn. 1996. Cell types involved in replication and distribution of human cytomegalovirus. Adv. Virus Res. 46:195-261.
58. Rasmussen, L., A. Geissler, C. Cowan, A. Chase, and M. Winters. 2002. The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates. J. Virol. 76:10841-10848.
59. Rawlinson, W. D., H. E. Farrell, and B. G. Barrell. 1996. Analysis of the complete DNA sequence of routine cytomegalovirus. J. Virol. 70:8833-8849.
60. Rice, G. P., R. D. Schrier, and M. B. Oldstone. 1984. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc. Natl. Acad. Sci. USA 81:6134-6138.
61. Shanley, J. D., J. Morningstar, and M. C. Jordan. 1985. Inhibition of murine cytomegalovirus lung infection and interstitial pneumonitis by acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine. Antimicrob. Agents Chemother. 28:172-175.
62. Skaletskaya, A., L. M. Bartle, T. Chittenden, A. L. McCormick, E. S. Mocarski, and V. S. Goldmacher. 2001. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. USA 98:7829-7834.
63. Smith, K. O., J. F. Thiel, J. T. Newman, E. Harvey, M. D. Trousdale, W. D. Gehle, and G. Clark. 1969. Cytomegaloviruses as common adventitious contaminants in primary African green monkey kidney cell cultures. J. Natl. Cancer Inst. 42:489-496.
64. Soderberg-Naucler, C., K. N. Fish, and J. A. Nelson. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119-126.
65. Spector, D. J., and M. J. Tevethia. 1994. Protein-protein interactions between human cytomegalovirus IE2-580aa and pUL84 in lytically infected cells. J. Virol. 68:7549-7553.
66. Stasiak, P. C., and E. S. Mocarski. 1992. Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2. J. Virol. 66:1050-1058.
67. Streblow, D. N., C. Soderberg-Naucler, J. Vieira, P. Smith, E. Wakabayashi, F. Ruchti, K. Mattison, Y. Altschuler, and J. A. Nelson. 1999. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99:511-520.
68. Strive, T., E. Borst, M. Messerle, and K. Radsak. 2002. Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture. J. Virol. 76:1252-1264.
69. Swack, N. S., O. C. Liu, and G. D. Hsiung. 1971. Cytomegalovirus infections of monkeys and baboons. Am. J. Epidemiol. 94:397-402.
70. Swanson, R., E. Bergquam, and S. W. Wong. 1998. Characterization of rhesus cytomegalovirus genes associated with antiviral susceptibility. Virology 240:338-348.
71. Theiler, R. N., and T. Compton. 2001. Characterization of the signal peptide processing and membrane association of human cytomegalovirus glycoprotein O. J. Biol. Chem. 276:39226-39231.
72. Uwaydat, S. H., and H. K. Li. 2002. Pigmentary retinopathy associated with intravitreal fomivirsen. Arch. Ophthalmol. 120:854-857.
73. Vink, C., E. Beuken, and C. A. Bruggeman. 2000. Complete DNA sequence of the rat cytomegalovirus genome. J. Virol. 74:7656-7665.
74. Vogel, P., B. J. Weigler, H. Kerr, A. G. Hendrickx, and P. A. Barry. 1994. Seroepidemiologic studies of cytomegalovirus infection in a breeding population of rhesus macaques. Lab. Anim. Sci. 44:25-30.
75. Weller, T. H. 1968. Serological differentiation of viruses responsible for cytomegalovirus inclusion disease. Virology 12:130-132.
76. Zhu, H., J. P. Cong, D. Yu, W. A. Bresnahan, and T. E. Shenk. 2002. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc. Natl. Acad. Sci. USA 99:3932-3937.
77. Zhu, L. A., and S. K. Weller. 1992. The six conserved helicase motifs of the UL5 gene product, a component of the herpes simplex virus type 1 helicaseprimase, are essential for its function. J. Virol. 66:469-479.
78. Zhu, Y., L. Huang, and D. G. Anders. 1998. Human cytomegalovirus oriLyt sequence requirements. J. Virol. 72:4989-4996.
79. Zini, N., M. C. Battista, S. Santi, M. Riccio, G. Bergamini, M. P. Landini, and N. M. Maraldi. 1999. The novel structural protein of human cytomegalovirus, pUL25, is localized in the viral tegument. J. Virol. 73:6073-6075.